Ongoing, Prospective Multicenter Safety Study of Subcutaneous Amifostine for Non-Small Cell Lung Cancer (NSCLC)
Go back to Resources
Ongoing, Prospective Multicenter Safety Study of Subcutaneous Amifostine for Non-Small Cell Lung Cancer (NSCLC)
Authors:
Secondary:
Location:
Go back to Resources